Neue Suche | Kongressdetail
mail
Druckansicht
 
 

Gene Therapy for Neurological Disorders

Evvnt Promotion / evvnt
-
06.12.2021 - 09.12.2021  The Colonnade Hotel, 120 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 8:30 am - 5:30 pm
 
Kongressthemen
Returning to Boston this December, the 3rd Gene Therapy for Neurological Disorders meeting will welcome discovery, preclinical, translational and clinical industry scientists to share, learn and network for the shared goal of successfully and safely delivering gene therapies to the CNS.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/853497-0?pid=4832

Speakers: Alan Foster, Chief Scientific Officer, Otonomy, Inc., Alexandra Watt, Lead Research Analyst, Beacon Targeted Therapies and more
 

Anfragen und Anmeldung:

https://go.evvnt.com/853497-1?pid=4832
Frau Ellie Saunders
 
Kategorien
Allgemeinmedizin, Klinische Forschung
Sprache
Englisch
Kongressgebühr
Full Access Pass - Physical - Standard Rate: USD 3593.00, Conference + Workshop Day OR Post Event Delivery Day - Physical - Standard Rate: USD 2846.00, Conference Only - Physical - Standard Rate: USD 2099.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Swiss Tropical and Public Health InstituteEuropean Public Health Association (EUPHA)Ärztekammer für WienAMREF - African Medical and Research FoundationAGEM - Arbeitsgemeinschaft Ethnologie und MedizinÖsterreichische Akademie der ÄrzteCenter of ExcellenceCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio Sanitario